Literature DB >> 5243796

The disapperance rate of skin-sensitizing antibody activity after intradermal administration.

R M Cass, B R Andersen.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 5243796     DOI： 10.1016/0021-8707(68)90129-9

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  9 in total

Review 1.  Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.

Authors:  Monica G Lawrence; Judith A Woodfolk; Alexander J Schuyler; Leland C Stillman; Martin D Chapman; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2016-07-14       Impact factor: 10.793

Review 2.  Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.

Authors:  J A Flick
Journal:  Bacteriol Rev       Date:  1972-09

3.  Induction of IgE-mediated immediate hypersensitivity to group I rye grass pollen allergen and allergoids in non-allergic man.

Authors:  D G Marsh; L M Lichtenstein; P S Norman
Journal:  Immunology       Date:  1972-06       Impact factor: 7.397

4.  Formation of rabbit reaginic antibodies to protein and hapten-protein conjugates.

Authors:  O Strannegård; A Yurchision
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

5.  A study of Prausnitz-Küstner reaction in leprosy.

Authors:  M M Mittal; K Saha; P L Shali; D N Shivpuri
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

6.  Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels.

Authors:  S C Dreskin; P K Goldsmith; W Strober; L A Zech; J I Gallin
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  The discovery of IgE 50 years later.

Authors:  Thomas A E Platts-Mills; Peter W Heymann; Scott P Commins; Judith A Woodfolk
Journal:  Ann Allergy Asthma Immunol       Date:  2016-03       Impact factor: 6.347

Review 8.  Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.

Authors:  Mohammad Fereydouni; Mona Motaghed; Elnaz Ahani; Tal Kafri; Kristen Dellinger; Dean D Metcalfe; Christopher L Kepley
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

9.  A search for synergy in the binding kinetics of Trastuzumab and Pertuzumab whole and F(ab) to Her2.

Authors:  Wai-Heng Lua; Samuel Ken-En Gan; David Philip Lane; Chandra Shekhar Verma
Journal:  NPJ Breast Cancer       Date:  2015-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.